Prevention of alcohol-heightened aggression by CRF-R1 antagonists in Mice: Critical role for DRN-PFC serotonin pathway

Neuropsychopharmacology

Volumn 39, Issue 12, 2014, Pages 2874-2883

  Quadros, Isabel M ^a,c   Hwa, Lara S ^a   Shimamoto, Akiko ^a   Carlson, Julia ^a   Debold, Joseph F ^a   Miczek, Klaus A ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3-(4-CHLORO-2-MORPHOLIN-4-YLTHIAZOL-5-YL)-8-(1-ETHYLPROPYL)-2,6-DIMETHYLIMIDAZO(1,2-B)PYRIDAZINE; ALCOHOL; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CENTRAL DEPRESSANT AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; PYRIDAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1A RECEPTOR; THIAZOLE DERIVATIVE;

AGGRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; DORSAL RAPHE NUCLEUS; DRINKING BEHAVIOR; DRUG EFFECTS; DRUG SELF ADMINISTRATION; METABOLISM; MOUSE; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; PSYCHOLOGY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AGGRESSION; ALCOHOL DRINKING; ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DORSAL RAPHE NUCLEUS; ETHANOL; MICE; NEURAL PATHWAYS; PREFRONTAL CORTEX; PYRIDAZINES; PYRIMIDINES; PYRROLES; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SELF ADMINISTRATION; SEROTONIN; SEROTONIN 5-HT1 RECEPTOR AGONISTS; THIAZOLES;

EID: 84939890430     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.139     Document Type: Article

References (64)

1. Amat J, Tamblyn JP, Paul ED, Bland ST, Amat P, Foster AC et al (2004). Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience 129:509-519.
2. Bannai M, Fish EW, Faccidomo S, Miczek KA (2007). Antiaggressive effects of agonists at 5-HT (1B) receptors in the dorsal raphe nucleus of mice. Psychopharmacology 193:295-304.
3. Beck SG, Pan YZ, Akanwa AC, Kirby LG (2004). Median and dorsal raphe neurons are not electrophysiologically identical. J Neurophysiol 91:994-1005.
4. Best M, Williams JM, Coccaro EF (2002). Evidence for a dysfunctional prefrontal circuit in patients with an impulsive aggressive disorder. Proc Natl Acad Sci USA 99:8448-8453.
5. Bushman BJ, Cooper HM (1990). Effects of alcohol on human aggression: integrative research review. Psychol Bull 107:341-354.
6. Caramaschi D, de Boer SF, de Vries H, Koolhaas JM (2008). Development of violence in mice through repeated victory along with changes in prefrontal cortex neurochemistry. Behav Brain Res 189:263-272.
7. Carpenter RE, Korzan WJ, Bockholt C, Watt MJ, Forster GL, Renner KJ et al (2009). Corticotropin releasing factor influences aggression and monoamines: modulation of attacks and retreats. Neuroscience 158:412-425.
8. Chalmers DT, Lovenberg TW, De Souza EB (1995). Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350.
9. Cloninger CR (1987). Neurogenetic adaptive mechanisms in alcoholism. Science 236:410-416.
10. D'Anna KL, Stevenson SA, Gammie SC (2005). Urocortin 1 and 3 impair maternal defense behavior in mice. Behav Neurosci 119:1061-1071.
11. de Almeida RM, Rosa MM, Santos DM, Saft DM, Benini Q, Miczek KA (2006). 5-HT1B receptors, ventral orbitofrontal cortex, and aggressive behavior in mice. Psychopharmacology (Berl) 185:441-450.
12. de Boer SF, Koolhaas JM (2005). 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur J Pharmacol 526:125-139.
13. Elkabir DR, Wyatt ME, Vellucci SV, Herbert J (1990). The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat. Regul Pept 28:199-214.
14. Faccidomo S, Bannai M, Miczek KA (2008). Escalated aggression after alcohol drinking in male mice: dorsal raphe and prefrontal cortex serotonin and 5-HT1B receptors. Neuropsychopharmacology 33:2888-2899.
15. Farrokhi C, Blanchard DC, Griebel G, Yang M, Gonzales C, Markham C et al (2004). Effects of the CRF1 antagonist SSR125543A on aggressive behaviors in hamsters. Pharmacol Biochem Behav 77:465-469.
16. Forster GL, Pringle RB, Mouw NJ, Vuong SM, Watt MJ, Burke AR et al (2008). Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity. Eur J Neurosci 28:299-310.
17. Funk CK, O'Dell LE, Crawford EF, Koob GF (2006). Corticotropinreleasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 26:11324-11332.
18. Gammie SC, Hasen NS, Stevenson SA, Bale TL, D'Anna KL (2005). Elevated stress sensitivity in corticotropin-releasing factor receptor 2 deficient mice decreases maternal, but not intermale aggression. Behav Brain Res 160:169-177.
19. Gammie SC, Negron A, Newman SM, Rhodes JS (2004). Corticotropin-releasing factor inhibits maternal aggression in mice. Behav Neurosci 118:805-814.
20. Gammie SC, Stevenson SA (2006). Intermale aggression in corticotropin-releasing factor receptor 1 deficient mice. Behav Brain Res 171:63-69.
21. Gehlert DR, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C et al (2007). 3-(4-Chloro-2-morpholin-4-ylthiazol-5-yl)-8-(1-ethylpropyl)-2, 6-dimethyl-imidazo[1, 2-b]pyridazine: a novel brain-penetrant, orally available corticotropinreleasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci 27:2718-2726.
22. Heilig M, Koob GF (2007). A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30:399-406.
23. Hostetler CM, Ryabinin AE (2013). The CRF system and social behavior: a review. Front Neurosci 7:92.
24. Huang MM, Overstreet DH, Knapp DJ, Angel R, Wills TA, Navarro M et al (2010). Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. J Pharmacol Exp Ther 332:298-307.
25. Hwa LS, DeBold JF, Miczek KA (2013). Alcohol in excess: CRF (1) receptors in the rat and mouse VTA and DRN. Psychopharmacology (Berl) 225:313-327.
26. Jacobs BL, Azmitia EC (1992). Structure and function of the brain serotonin system. Physiol Rev 72:165-229.
27. Kirby LG, Pernar L, Valentino RJ, Beck SG (2003). Distinguishing characteristics of serotonin and non-serotonincontaining cells in the dorsal raphe nucleus: electrophysiological and immunohistochemical studies. Neuroscience 116:669-683.
28. Kirby LG, Rice KC, Valentino RJ (2000). Effects of corticotropinreleasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22:148-162.
29. Knapp DJ, Overstreet DH, Huang M, Wills TA, Whitman BA, Angel RA et al (2011). Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats. Psychopharmacology 218:179-189.
30. Krug EG, Dahlberg LL, Mercy JA, Zwi AB, Lozito R (eds) (2002). World Report on Violence and Health. World Health Organization: Geneva.
31. Lowry CA, Rodda JE, Lightman SL, Ingram CD (2000). Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J Neurosci 20:7728-7736.
32. Lukkes JL, Forster GL, Renner KJ, Summers CH (2008). Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphe differentially affect serotonin release in the nucleus accumbens. Eur J Pharmacol 578:185-193.
33. Mele A, Cabib S, Oliverio A, Melchiorri P, Puglisi-Allegra S (1987). Effects of corticotropin releasing factor and sauvagine on social behavior of isolated mice. Peptides 8:935-938.
34. Merlo Pich E, Lorang M, Yeganeh M, Rodriguez De Fonseca F, Raber J et al (1995). Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15:5439-5447.
35. Miczek KA, Barros HM, Sakoda L, Weerts EM (1998). Alcohol and heightened aggression in individual mice. Alcohol Clin Exp Res 22:1698-1705.
36. Miczek KA, de Almeida R M M (2001). Oral drug self-administration in the home cage of mice: alcohol-heightened aggression and inhibition by the 5-HT1B agonist anpirtoline. Psychopharmacology (Berl) 157:421-429.
37. Miczek KA, de Boer SF, Haller J (2013). Excessive aggression as model of violence: a critical evaluation of current preclinical methods. Psychopharmacology (Berl) 226:445-458.
38. Miczek KA, Fish EW, de Almeida R M M, Faccidomo S, DeBold JF (2004). Role of alcohol consumption in escalation to violence. Ann NY Acad Sci 1036:278-289.
39. Miczek KA, O'Donnell JM (1978). Intruder-evoked aggression in isolated and nonisolated mice: effects of psychomotor stimulants and l-dopa. Psychopharmacology 57:47-55.
40. Molliver ME (1987). Serotonergic neuronal systems: what their anatomic organization tells us about function. J Clin Psychopharmacol 7:3S-23S.
41. National Research Council of The National Academies (2010). Guide for the Care and Use of Laboratory Animals. 8th edn. The National Academies Press: Wahington, DC.
42. Olive MF, Koenig HN, Nannini MA, Hodge CW (2002). Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav 72:213-220.
43. Olivier B (2004). Serotonin and aggression. Ann NY Acad Sci 1036:382-392.
44. Paxinos G, Franklin K B J (2001). The Mouse Brain in Stereotaxic Coordinates, 2nd edn. Academic Press: San Diego.
45. Price ML, Curtis AL, Kirby LJ, Valentino RJ, Lucki I (1998). Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18:492-502.
46. Price ML, Lucki I (2001). Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci 21:2833-2841.
47. Raine A, Buchsbaum MS, Stanley J, Lottenberg S, Abel L, Stoddard J (1994). Selective reductions in prefrontal glucose metabolism in murderers. Biol Psychiatry 36:365-373.
48. Roizen J (1997). Epidemiological issues in alcohol-related violence. In: Galanter M (ed). Recent Developments in Alcoholism. Plenum Press: New York, pp 7-41.
49. Seymour PA, Schmidt AW, Schulz DW (2003). The pharmacology of CP-154, 526, a non-peptide antagonist of the CRH1 receptor: a review. CNS Drug Rev 9:57-96.
50. Shimamoto A, DeBold JF, Holly EN, Miczek KA (2011). Blunted accumbal dopamine response to cocaine following chronic social stress in female rats: exploring a link between depression and drug abuse. Psychopharmacology (Berl) 218:271-279.
51. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M et al (1996). CP-154, 526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 93:10477-10482.
52. Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS et al (2008). Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol Psychiatry 63:139-145.
53. Sparta DR, Sparrow AM, Lowery EG, Fee JR, Knapp DJ, Thiele TE (2008). Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res 32:259-265.
54. Sprouse JS, Aghajanian GK (1987). Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1:3-9.
55. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983). Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165-186.
56. Takahashi A, Kwa C, DeBold JF, Miczek KA (2010a). GABA (A) receptors in the dorsal raphé nucleus of mice: escalation of aggression after alcohol consumption. Psychopharmacology 211:467-477.
57. Takahashi A, Miczek KA (2013). Neurogenetics of aggressive behavior: studies in rodents. Curr Top Behav Neurosci (e-pub ahead of print 7 December 2013; doi:10.1007/7854-2013-263).
58. Takahashi A, Quadros IM, de Almeida RM, Miczek KA (2011). Brain serotonin receptors and transporters: initiation vs termination of escalated aggression. Psychopharmacology (Berl) 213:183-212.
59. Takahashi A, Shimamoto A, Boyson CO, DeBold JF, Miczek KA (2010b). GABA (B) receptor modulation of serotonin neurons in the dorsal raphe nucleus and escalation of aggression in mice. J Neurosci 30:11771-11780.
60. Tazi A, Dantzer R, Le Moal M, Rivier J, Vale W, Koob GF (1987). Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats. Regul Pept 18:37-42.
61. Valentino RJ, Commons KG (2005). Peptides that fine-tune the serotonin system. Neuropeptides 39:1-8.
62. Valentino RJ, Lucki I, Van Bockstaele E (2010). Corticotropinreleasing factor in the dorsal raphe nucleus: linking stress coping and addiction. Brain Res 1314:29-37.
63. van Erp AM, Miczek KA (2000). Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. J Neurosci 20:9320-9325.
64. Will MJ, Der-Avakian A, Bland ST, Grahn RE, Hammack SE, Sparks PD et al (2004). Electrolytic lesions and pharmacological inhibition of the dorsal raphe nucleus prevent stressor potentiation of morphine conditioned place preference in rats. Psychopharmacology (Berl) 171:191-198.